BioSpace News Archive

Startup Receives $150K Grand Prize for Artificial Intelligence-Driven Robotics System to Expedite Diagnosis of Critical Illnesses

NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 third quarter financial results before the opening of the market on Thursday, October 17, 2019.

Alzheimer’s disease affects millions of lives around the world every year according to the 2018 World Alzheimer’s Report, but both the cause and cure to the disease remain a mystery to the medical field.

Diana Borges, MediSpend vice president of compliance solutions, and Katie Jacyna, MediSpend senior product manager, will discuss overcoming the challenges around managing engagements with healthcare professionals (HCP) and healthcare organizations (HCO) at CBI’s 3rd Annual Managing HCP Interactions Conference.

Peterson will begin her position on October 14, reporting directly to Rasu Shrestha, Atrium Health’s executive vice president and chief strategy officer.

Second Offering in PREVENA RESTOR™ Therapy Portfolio Targets Post-Operative Incisions and Surrounding Soft Tissue, Helping Reduce Edema, Which May Facilitate Early Mobility

Cyclists collectively rode more than 90,000 miles through Pennsylvania to raise awareness about kidney disease

Baxter also recently named one of Working Mother’s 2019 ‘100 Best Companies’

Young adults, JDRF’s CEO, researchers discuss long-term impact of the current insulin affordability crisis in Perspectives on Insulin Pricing, a special issue of Evidence-Based Diabetes Management™

Bio-Techne Corporation (NASDAQ:TECH) today announced that the Medicare Administrative Contractor (MAC) National Government Services, Inc. issued a final Local Coverage Decision (LCD) covering the ExoDx Prostate(IntelliScore) – EPI – test for men who are being considered for an initial prostate biopsy